8 news items
Surging Biotech M&A Reaffirms Massive Opportunity In Rare Disease Drug Development
AZN
CRDL
NVO
11 Jun 24
Securities Litigation Reform Act of 1995 provides investors a safe harbor in regard to forward-looking statements. Any statements that express or involve
I-Mab Appoints Phillip Dennis, MD, PhD, as Chief Medical Officer
AZN
IMAB
SNY
6 Jun 24
harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology
Zantac Heart Burn Continues For GSK As US Court Ruling Allows Thousands Of Zantac Lawsuits To Move Forward
GSK
SNY
3 Jun 24
(ranitidine).
The State Court’s decision contradicts the Federal Court’s Multidistrict Litigation ruling under
Fulcrum Therapeutics Enters into a Collaboration and License Agreement with Sanofi for the Development and Commercialization of Losmapimod in Facioscapulohumeral Muscular Dystrophy
FULC
SNY
13 May 24
This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 that involve
Pfizer Agrees To Settle Over 10,000 Lawsuits About Cancer Risks Associated With Discontinued Heartburn Drug Zantac
GSK
PFE
SNY
8 May 24
the largest resolution in the litigation
9l0s07xivi99fvzehtj0 xkvcft9waju
SNY
25 Apr 24
Burn Drug Zantac’s Litigation Saga, Sanofi Nears Settlement in Major Lawsuit Cluster
cph588qxc3gazew049d8ibhaf9runy83p4ub13jp2js6hdygdjzzppbv
SNY
17 Apr 24
: In Heart Burn Drug Zantac’s Litigation Saga, Sanofi
ck8yya2xcwl zoo41sn8vpp5igk9hhx8qq8xxhx4esy8zvbc
GSK
PFE
SNY
4 Apr 24
such litigations.
The settlement with plaintiffs' lawyers aims to conclude most pending cases, allowing Sanofi
- Prev
- 1
- Next